Radiation Oncology

Introduction to the Department of Radiation Oncology, Zhongshan Hospital Affiliated with Xiamen University I. Basic Profile, Qualifications and Honors The Department of Radiation Oncology of Zhongshan Hospital Affiliated with Xiamen University was established in May 2001. It has always upheld the service philosophy “Patients First, Service First,” and is committed to building a key discipline of a major university-affiliated hospital. It is a benchmark discipline for precision radiotherapy of cancer in southern Fujian. The department owns **mainland China’s first Varian TrueBeam dual-rotating-gantry accelerator**, and its hardware platform has reached the highest domestic level. It admits more than 1,000 radiotherapy patients annually and has repeatedly shared its experience as an industry benchmark at provincial radiotherapy quality-control conferences. It has successively been recognized as the “Fujian Provincial Demonstration Ward for Standardized CINV Management” and the national “Demonstration Ward for Standardized Radiotherapy Nutritional Therapy,” establishing a leading position in China in both radiotherapy and nutritional therapy. The department’s ward is on the 16th floor of Building 3, with 55 open beds and a view of Yundang Lake outside the windows, providing patients with a comfortable environment for medical care and recuperation. The department has established a high-precision, intelligent modern radiotherapy equipment system, equipped with a Varian TrueBeam dual-rotating-gantry accelerator, Varian 23EX linear accelerator, three-dimensional treatment-planning system, Siemens large-bore CT simulator, and precision verification equipment including PTW dosimeters and MAPCHECK planar dosimeters, comprehensively improving treatment accuracy and safety. Third-party endorsement: The discipline leader holds important positions in national academic societies; multiple clinical research achievements have participated in international and domestic multicenter clinical trials; and technical achievements have been promoted and exchanged on the provincial radiotherapy quality-control platform. Diagnostic and treatment quality is continuously subject to routine supervision and inspection by provincial and municipal radiotherapy quality-control centers. The department maintains academic exchanges with several leading domestic cancer centers. Its treatment protocols and quality-control system have received authoritative recognition from domestic peers, making it a benchmark for standardized cancer radiotherapy in southern Fujian. II. Core Diagnostic and Treatment Scope The department focuses on precision radiotherapy for common malignant tumors, including head and neck tumors, lung cancer, liver cancer, esophageal cancer, breast cancer, brain tumors, and abdominal and pelvic tumors. It also provides palliative radiotherapy for advanced tumors. It has accumulated extensive experience in individualized comprehensive treatment of complex and difficult tumors, providing patients with standardized, full-cycle medical services from diagnosis and treatment through rehabilitation. III. Specialized Subdisciplines and Core Technical Advantages (1) Molecular-imaging-guided precision radiotherapy The department provides internationally advanced technologies, including molecular-imaging-guided precision radiotherapy and stereotactic radiosurgery (SBRT/SRS), benefiting cancer patients. The team led by Professor Lin Qin has completed more than 6,000 cases of molecular-imaging-guided precision radiotherapy. The efficacy of SBRT for early-stage lung cancer is already comparable to surgery, enabling patients to achieve equivalent efficacy while avoiding surgical trauma. Relying on **mainland China’s first dual-rotating-gantry device**, the department can perform multi-angle, dual-rotation intensity-modulated radiosurgery, precisely focus on tumor target volumes, maximally protect surrounding normal tissues and organs, and treat multiple targets simultaneously, substantially improving the precision and efficiency of radiotherapy for complex tumors. (2) Conventional precision radiotherapy techniques The department comprehensively performs advanced precision radiotherapy techniques, including three-dimensional conformal radiotherapy, conformal intensity-modulated radiotherapy, volumetric-modulated arc therapy, image-guided radiotherapy, stereotactic radiosurgery, and spatially fractionated radiotherapy, covering the diagnostic and treatment needs of all tumor patients suitable for radiotherapy and ensuring treatment precision and efficacy. IV. Multidisciplinary MDT Comprehensive Diagnosis and Treatment and Full-Course Management The department strictly implements the three-tier physician ward-round system and provides individualized comprehensive treatment plans for patients with complex and difficult tumors, connecting the entire diagnostic, treatment, and rehabilitation pathway and delivering standardized full-cycle care. The nursing team implements holistic nursing and humanized management, conducting one-to-one narrative therapy or group psychological counseling every week. While ensuring the effectiveness of cancer treatment, it also attends to patients’ psychological status and provides integrated physical and emotional care. V. Talent Team and Expert Strength The department is headed by Professor Lin Qin, Secretary of the Party Committee of Zhongshan Hospital Affiliated with Xiamen University and a national expert in radiation oncology. Professor Lin is a chief physician and doctoral supervisor, receives the State Council Special Government Allowance, has received honors including “National Renowned Physician · Outstanding Conduct” (6th edition), and holds several national academic positions, including Deputy Chair of the Radiation Oncology Therapeutics Committee of the Chinese Anti-Cancer Association. Under Professor Lin’s leadership, the department has assembled a professionally structured team with coordinated development in medicine, technology, and nursing. It currently has 9 chief physicians, 4 deputy chief physicians, 2 master’s supervisors, and several high-level professionals who returned from study in France or the United States. The team’s senior, middle-aged, and young members complement one another; they possess excellent technical skills and humanistic care, providing talent support for high-quality diagnosis and treatment. VI. Coordinated Development of Medical Care, Education and Research (1) Medical services The department is always patient-centered. Relying on its high-precision intelligent radiotherapy equipment system, including mainland China’s first dual-rotating-gantry accelerator, and mature precision radiotherapy technologies, it provides standardized and precise radiotherapy for patients with various tumors. Drawing on its experience in building demonstration wards for standardized CINV management and radiotherapy nutritional therapy, it also provides supportive medical services such as management of treatment-related adverse reactions and nutritional support, ensuring treatment safety and patients’ quality of life. (2) Education and training The department has 2 master’s supervisors and undertakes relevant teaching and clinical internship supervision for Xiamen University, Fujian Medical University, Zhangzhou Health School, and other institutions. It provides continuing training in radiotherapy techniques for professionals nationwide and continuously advances the cultivation of radiotherapy specialists. (3) Research and innovation The department conducts clinical and basic research in core areas including molecular-imaging-guided precision radiotherapy and stereotactic radiosurgery. It has completed several thousand treatments, undertaken multiple provincial and municipal research projects, and participated in more than ten international and domestic multicenter clinical trials. Its experience in clinical application of relevant technologies has repeatedly been shared at provincial radiotherapy quality-control conferences, promoting more uniform regional standards of precision radiotherapy. VII. Summary of the Department’s Core Advantages Its advanced equipment leads nationally: it owns **mainland China’s first Varian TrueBeam dual-rotating-gantry accelerator**, combined with a complete set of high-end radiotherapy equipment, enabling ultra-precise stereotactic radiosurgery, precise target localization, and outstanding protection of normal tissues. Its core precision radiotherapy technologies are highly competitive: molecular-imaging-guided precision radiotherapy and SBRT/SRS are maturely applied; SBRT for early-stage lung cancer achieves results comparable to surgery; more than 6,000 cases of molecular-imaging-guided precision radiotherapy have been completed, giving the department regional leadership. Its discipline leader has strong industry influence: Professor Lin Qin, a “National Renowned Physician” receiving the State Council Special Allowance and holding national academic positions, leads a team that includes many high-level returnees, with complementary seniority and solid expertise. Its specialty-disease management qualifications are strong: it has been recognized as both a provincial demonstration ward for standardized CINV management and a national demonstration ward for standardized radiotherapy nutritional therapy, developing distinctive strengths in radiotherapy-related adverse-reaction management and nutritional support. Its full-cycle physical and psychological care is distinctive: it strictly implements core medical systems such as three-tier ward rounds and provides humanized nursing and routine psychological counseling, offering care that values both body and mind. Its regional benchmark position is clear: as the benchmark discipline for precision cancer radiotherapy in southern Fujian, it treats more than 1,000 radiotherapy patients annually, has repeatedly shared experience on provincial quality-control platforms, undergoes routine assessment by superior quality-control authorities, has gained recognition from domestic peers, and plays a leading regional role. VIII. Department Vision The department will always uphold the理念 “Patients First, Service First,” rely on the technical advantages of mainland China’s first dual-rotating-gantry device, continue to deepen its work in precision cancer radiotherapy, continuously improve its diagnostic and treatment technology system and full-cycle service model, and steadily advance toward becoming a key discipline of a key university-affiliated hospital. It will provide more precise and compassionate care to more cancer patients and safeguard the light of life for people with cancer.